This phenomenon might further elucidate the mechanism underlying the regulation of α‐synuclein levels in PARK4 patients, who are healthy even before the earlier onset of PD, and also in sporadic PD patients who account for ~ 90% of all PD cases. This evidence concerns the gene SNCA and Parkinson disease.